Sialidosis type II: Expansion of phenotypic spectrum and identification of a common mutation in seven patients
Sialidosis, an autosomal recessive disorder, is characterized by progressive lysosomal storage of sialylated glycopeptides and oligosaccharides. It occurs as a result of biallelic mutations in the NEU1 gene. Sialidosis is traditionally classified as a milder, late-onset type I and a severe early-ons...
Main Authors: | Veronica Arora, Nitika Setia, Ashwin Dalal, Maria Celestina Vanaja, Deepti Gupta, Tinku Razdan, Shubha R. Phadke, Renu Saxena, Anshu Rohtagi, Ishwar C. Verma, Ratna Dua Puri |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Molecular Genetics and Metabolism Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426919301697 |
Similar Items
-
Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I
by: Rosario Mosca, et al.
Published: (2020-03-01) -
Mutation–proved Clouston syndrome in a large Indian family with a variant phenotype
by: Sangeeta Khatter, et al.
Published: (2019-01-01) -
Seizure remission and improvement of neurological function in sialidosis with perampanel therapy
by: Su-Ching Hu, et al.
Published: (2018-01-01) -
Genetic and clinical characterization of mainland Chinese patients with sialidosis type 1
by: Xiaoxu Han, et al.
Published: (2020-08-01) -
Type 1 sialidosis presenting with ataxia, seizures and myoclonus with no visual involvement
by: Ahmed N. Mohammad, et al.
Published: (2018-06-01)